Methylenedioxybutylamphetamine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Methylenedioxybutylamphetamine
MDBU.png
Names
Preferred IUPAC name
N-[1-(2H-1,3-Benzodioxol-5-yl)propan-2-yl]butan-1-amine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C14H21NO2/c1-3-4-7-15-11(2)8-12-5-6-13-14(9-12)17-10-16-13/h5-6,9,11,15H,3-4,7-8,10H2,1-2H3
    Key: RDXVRDCQDITVDV-UHFFFAOYSA-N
  • C1=C2C(=CC=C1CC(C)NCCCC)OCO2
Properties
C14H19NO2
Molar mass 233.311 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Methylenedioxybutylamphetamine (MDBU or 3,4-methylenedioxy-N-butylamphetamine) is a lesser-known psychedelic drug. It is also the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA). MDBU was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 40 mg, and the duration unknown.[1] MDBU produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDBU.

See also[edit]

References[edit]